Edition:
United States

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

6.18USD
16 Feb 2018
Change (% chg)

$-0.05 (-0.80%)
Prev Close
$6.23
Open
$6.25
Day's High
$6.74
Day's Low
$6.16
Volume
624,336
Avg. Vol
265,559
52-wk High
$7.10
52-wk Low
$0.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.222
Jun '17 0.00 -0.214
Mar '17 0.00 -0.234
FY 2016 Dec '16 0.00 -0.183
Sep '16 0.00 -0.200
Jun '16 0.00 -0.216
Mar '16 0.00 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.17 -0.16 -0.18 -0.22
Quarter Ending Jun-18 2 -0.17 -0.16 -0.18 -0.23
Year Ending Dec-18 4 -0.74 -0.60 -0.86 -1.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) -- 140.57 8.57
Price to Book (MRQ) 79.12 18.76 5.14
Price to Tangible Book (MRQ) 99.44 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 20.40 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -10.76 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago 53.38 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 1.20 6.17 3.38
LT Debt to Equity (MRQ) 0.00 16.64 11.85
Total Debt to Equity (MRQ) 142.88 18.80 15.12
Interest Coverage (TTM) -8.79 -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -- -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -- -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -- -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,305,201 819,569,446
Net Income/Employee (TTM) -- -626,600 95,804,981
Receivable Turnover (TTM) -- 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -143.04 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -323.08 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -323.62 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 75.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Viking Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.42%
# of Holders: 32
Total Shares Held: 9,271,317
3 Mo. Net Change: 7,249,327
# New Positions: 21
# Closed Positions: 7
# Increased Positions: 28
# Reduced Positions: 8
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.